期刊文献+

胰岛素受体基因17外显子点突变的测得 被引量:4

The novel mutations in exon 17 of insulin receptor gene in patients with acanthosis nigricans and their close relatives
原文传递
导出
摘要 目的 阐述胰岛素受体基因缺陷与胰岛素抵抗发生机制间的关系。方法 运用PCR 单链构型多态性技术 ,对 9个黑棘皮病家系 (计 9例患者 ,2 3例他们的一级亲属 )进行了该基因 17外显子筛查工作 ,对其中带型异常者进行了DNA直接测序确认。结果 发现了 3个既往未报道过的错义突变和 5个沉默多态性 (slientpolymorphism) ,即杂合子突变Val983 →Met,纯合突变Gln10 0 4 →Lys、纯合突变Gly10 2 2 →Lys、Pro980 (CCA→CCC)、Leu10 0 2 (CTG→CTT)、Gln10 0 4 (CAA→CAG)、Gly10 0 8(GGC→GGT)、Glu10 3 4(GAG→GAA)。结论 上述突变可能是造成黑棘皮病患者胰岛素抵抗的主要原因。 Objective Insulin resistance clearly exists in patients with acanthosis nigricans (AN) To elucidate the mechanisms of insulin resistance in the patients with AN is very important so as to have a better understanding of non insulin dependent diabetes mellitus (NIDDM) and its related disorders Methods The techniques of PCR single strand conformation polymorphism (SSCP) and DNA direct sequencing were applied to examine the mutations and polymorphisms in the exon 17 of insulin receptor (IR) gene in 9 patients with AN and their 23 first degree relatives Results In total, 8 variant SSCP patterns were detected Direct sequencing revealed 3 point mutations, i e homozygous Val 983 → Met(GTG→ATG), homozygous Gln 1004 →Lys (CAG→AAG), heterozygous Gly 1022 →Lys(GAA→AAG) and 5 silent polymorphisms in Pro 980 (CCA CCC), Leu 1002 (CTG→CTT), Gln 1004 (CAA→CAG), Gly 1008 (GGC→GGT)and Glu 1034 (GAG→GAA) All of the three point mutations have not been mentioned in the previous literature Conclusion It is suggested that mutations in the IR gene tyrosine kinase domain causes defective kinase activity and insulin resistance
出处 《中华内科杂志》 CAS CSCD 北大核心 2000年第3期174-177,I005,共5页 Chinese Journal of Internal Medicine
基金 国家自然科学发展基金!3 9170 3 74
关键词 基因突变 胰岛素抵抗 胰岛素受体 Insulin receptors Genes Mutation Insulin resistance
  • 相关文献

参考文献1

  • 1Chen C,Endocrinology,1996年,137期,846页

同被引文献29

  • 1戴星.黑棘皮病[J].国外医学(皮肤性病学分册),1995,21(6):350-352. 被引量:6
  • 2张丽萍,巫毅,姜桂英,毓明涛,张民夫.儿童良性黑棘皮病伴肥胖与高胰岛素血症[J].中华皮肤科杂志,1996,29(6):397-398. 被引量:3
  • 3KahnCR, WairGC. Joslins Diabetes Mellitus. 13 Edition[M]. Phil-adelphia: Published by Lea Febiger Company, 1995:139-144
  • 4Taira M, Hashimoto N. Insulin receptor abnormality and its clinical aspect [J].Nippon Rinsho, 1998, 56:1866-1870
  • 5刘永学,纪学武扁沛永.基岗突变的分子生物学方法检测及其在新药临床前遗传毒性评价中的应用前景[J].医学科学院院刊,2000,24(3):86-88.
  • 6LIGUORI M, URSO R, FATIGANTE G. Insulin resistance: re- ceptor and post-receptor abnormalities [J]. Minerva Endocrinol, 1998, 23(2): 37-52.
  • 7STEINM?LLER TH, STOCKMANN M, BECHSTEIN WO, et al. Liver transplantation and diabetes mellitus[J]. Exp clin Endocrinol Diabetes, 2000, 108(6): 401-405.
  • 8Clauster E. Insulin receptor and diabetes[J]. Rev Prat, 1994, 44 (9): 1154-1162.
  • 9SEINO S, SEINO M, NISHI S, et al. Structure of the human insulin receptor gene and characterization of its promoter[J]. Proc Natl Acad Sci USA, 1989, 86(1): 114-118.
  • 10SEINO S, BElL GI. Alternative splicing of human insulin receptor messenger RNA[J]. Biophys Res Commun, 1989, 159(1): 312-316.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部